UCAP-Q病例发现问卷的衍生与验证:识别未诊断的哮喘和慢阻肺
研究通过随机 digit 拨号招募有呼吸道症状且无既往诊断的社区成人,用支气管舒张前后肺功能确认哮喘或慢阻肺,开发并验证了13条目UCAP-Q问卷。衍生样本(n=1615)中,6%风险切点对哮喘和慢阻肺的敏感性分别为92%和97%,AUC分别为0.69和0.82;独立样本(n=471)验证敏感性为93%和92%,AUC为0.70和0.81。
要点
- UCAP-Q问卷对未诊断哮喘和慢阻肺具有高敏感性,适合病例发现。
- 6%风险切点下特异性较低,阳性结果需肺功能确认。
- UCAP-Q的AUC优于目前推荐的病例发现问卷。
核心结论
- UCAP-Q对识别未诊断的哮喘或慢阻肺表现出高敏感性和AUC,并提供了网页计算器便于计算各疾病风险概率。
研究设计与样本
- 通过随机 digit 拨号招募社区成人,纳入无既往医生诊断肺病且自报呼吸道症状者,用支气管舒张前后肺功能确认哮喘或慢阻肺。
- 采用多项 logistic 回归后退法选择预测问题,评估敏感性、预测值和AUC,并评估重测信度、可接受性和可读性。
- 在独立样本中前瞻性外部验证并重新评估预测性能。
主要发现
- 衍生样本(n=1615)中,6%风险切点对哮喘敏感性92%、对慢阻肺敏感性97%,特异性17%,哮喘AUC 0.69(95% CI 0.64-0.74),慢阻肺AUC 0.82(95% CI 0.78-0.86)。
- 独立验证样本(n=471)中,哮喘敏感性93%、慢阻肺敏感性92%,特异性19%,哮喘AUC 0.70(95% CI 0.62-0.79),慢阻肺AUC 0.81(95% CI 0.74-0.87)。
- UCAP-Q的AUC高于目前推荐的哮喘或慢阻肺病例发现问卷的AUC。
关键数值与推荐
- UCAP-Q为13条目问卷,预测未诊断哮喘或慢阻肺,最合适风险切点为6%。
- 衍生样本中6%切点敏感性:哮喘92%、慢阻肺97%,特异性17%。
- 验证样本中6%切点敏感性:哮喘93%、慢阻肺92%,特异性19%。
临床怎么用
- 对社区中有呼吸道症状但无既往肺病诊断的成人,可用UCAP-Q进行病例发现。
- 6%风险切点下敏感性高但特异性低,阳性者应通过肺功能确诊。
- 网页计算器可辅助计算个体哮喘和慢阻肺风险概率。
局限性
- 原文摘要未报告正式局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many people with asthma and COPD remain undiagnosed. We developed and validated a new case-finding questionnaire to identify symptomatic adults with undiagnosed obstructive lung disease. METHODS: Adults in the community with no prior history of physician-diagnosed lung disease who self-reported respiratory symptoms were contacted via random-digit dialling. Pre- and post-bronchodilator spirometry was used to confirm asthma or COPD. Predictive questions were selected using multinomial logistic regression with backward elimination. Questionnaire performance was assessed using sensitivity, predictive values and area under the receiver operating characteristic curve (AUC). The questionnaire was assessed for test-retest reliability, acceptability and readability. External validation was prospectively conducted in an independent sample and predictive performance re-evaluated. RESULTS: A 13-item Undiagnosed COPD and Asthma Population Questionnaire (UCAP-Q) case-finding questionnaire to predict undiagnosed asthma or COPD was developed. The most appropriate risk cut-off was determined to be 6% for either disease. Applied to the derivation sample (n=1615), the questionnaire yielded a sensitivity of 92% for asthma and 97% for COPD; specificity of 17%; and an AUC of 0.69 (95% CI 0.64-0.74) for asthma and 0.82 (95% CI 0.78-0.86) for COPD. Prospective validation using an independent sample (n=471) showed sensitivities of 93% and 92% for asthma and COPD, respectively; specificity of 19%; with AUCs of 0.70 (95% CI 0.62-0.79) for asthma and 0.81 (95% CI 0.74-0.87) for COPD. AUCs for UCAP-Q were higher compared to AUCs for currently recommended case-finding questionnaires for asthma or COPD. CONCLUSIONS: The UCAP-Q demonstrated high sensitivities and AUCs for identifying undiagnosed asthma or COPD. A web-based calculator allows for easy calculation of risk probabilities for each disease.
引用
- Huynh C, Whitmore GA, Vandemheen KL, et al. Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPD. Eur Respir J. 2022. PMID: 35332067. doi:10.1183/13993003.03243-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。